- Marc Righini1⇑,
- Christelle Jobic2,
- Françoise Boehlen1,
- Jean Broussaud3,
- François Becker1,
- Morgan Jaffrelot4,
- Marc Blondon1,
- Bruno Guias5,
- Grégoire Le Gal2,
- the EDVIGE study group
- 1Division of Angiology and Hemostasis, Department of Medical Specialties, Geneva University Hospital and Faculty of Medicine, Geneva, Switzerland
- 2Université de Brest, INSERM CIC 05-02; CHU de la Cavale Blanche, Brest, France
- 3Department of Vascular Diseases, Centre Hospitalier Bretagne Atlantique, Vannes, France
- 4Emergency Department, CHU de la Cavale Blanche, Brest, France
- 5Vascular Medicine Physician, Morlaix, France
Contributors from the EDVIGE study group: Mohamed BABA-AHMED (Algiers), Dominique BERNARD (Carhaix), Henri BOUNAMEAUX (Genève), Luc BRESSOLLETTE (Brest), Paul CIRAFICI (Geneva), Cécile DE GAIL SAUTERON (Saint-Grégoire), Philippe DE MOERLOOSE (Genève), Aurélien DELLUC (Brest), Marie-Annick DIRER (Brest), Catherine DUIGOU-BIHi (Lorient), Pierre FONTANA (Geneva), Jacques GESTIN (Quimper), Salah GUEDDI (Geneva), Bruno GUICHAOUA (Quimper), Patrice HUDO (Saint-Brieuc), Nathalie JOURNEAUX (Rennes), Raymond KACZMAREK (Quimper), Geneviève KERCRET (Rennes), Marie-Luce LABALETTE (Lannion), Dominique LE BERRE (Paimpol), Isabelle LEBORGNE (Rennes), Marie-Pierre LE GOC PEDELUCQ (Lorient), Dominique LE MENN BUREAU (Pontivy), Fabrice LE THOER (Brest), Patrick LOUIS (Brest), Stéphanie LOUIS (Brest), Geneviève MADEC BOUGEARD (Lannion), Mario MAUFUS (Grenoble), Catherine NOEL MOREL (Pacé), Karine PICHON (Vannes), Emmanuel PLAT (Brest), Laurent PRUVOST (Saint-Malo), Philippe QUEHE (Brest), Edith RIVOAL (Quimper), Eric THULLIEZ (Rennes), Johny VOGEL (Sierre), Robert WUTSCHERT (Neuchatel).
The assessment of clinical probability represents an important step in the diagnostic strategy of patients with suspected deep vein thrombosis. The recently derived LEFt clinical prediction rule for pregnant women combines three variables: symptoms in the left leg (L), calf circumference difference of 2 centimeters or over (E for edema) and first trimester presentation (Ft) but is lacking an external validation. The LEFt rule was computed among pregnant women with suspected deep vein thrombosis who were included in a multicenter prospective diagnostic management outcome study. We calculated the proportion of women and the prevalence of deep vein thrombosis in each probability group, along with the diagnostic performances of the LEFt rule. All variables needed to compute the rule could be retrieved in 157 of the 167 pregnant women with suspected deep vein thrombosis. The prevalence of confirmed deep vein thrombosis was 13 of 157 (8.3%). The LEFt rule was negative in 46 (29%) women. A deep vein thrombosis was diagnosed in 13 of 111 (11.7%, 95% Confidence Interval (CI): 8.3-20.9%) of women with at least one of the LEFt criteria, as compared with none of 46 (0.0%, 95%CI: 0.0-7.9%) of women with none of the LEFt criteria. These results suggest that a negative LEFt rule accurately identifies pregnant women in whom the proportion of confirmed deep vein thrombosis appears to be very low. The rule should not be used as stand-alone test for excluding DVT during pregnancy, but might rather be implemented in a diagnostic strategy in association with D-dimer measurement and compression ultrasonography. The original trial was registered at clinicaltrials.gov (NCT 00740454).
Authorship and Disclosures: Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org.
- Received June 12, 2012.
- Accepted September 19, 2012.
- Copyright© 2013 Ferrata Storti Foundation